BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20202651)

  • 1. Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
    Kingwell E; Leung AL; Roger E; Duquette P; Rieckmann P; Tremlett H;
    J Neurol Sci; 2010 May; 292(1-2):57-62. PubMed ID: 20202651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the ascertainment of multiple sclerosis.
    Marrie RA; Cutter G; Tyry T; Hadjimichael O; Campagnolo D; Vollmer T
    Neurology; 2005 Oct; 65(7):1066-70. PubMed ID: 16217060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease onset in familial and sporadic primary progressive multiple sclerosis.
    Koch M; Zhao Y; Yee I; Guimond C; Kingwell E; Rieckmann P; Sadovnick D; Tremlett H;
    Mult Scler; 2010 Jun; 16(6):694-700. PubMed ID: 20378663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis in Australia: prognostic factors.
    Hammond SR; McLeod JG; Macaskill P; English DR
    J Clin Neurosci; 2000 Jan; 7(1):16-9. PubMed ID: 10847644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The onset of multiple sclerosis in Greece: a single-center study of 1,034 consecutive patients.
    Koutsis G; Evangelopoulos ME; Andreadou E; Mandellos D; Karachalios G; Potagas C; Karantoni E; Karouli M; Chrysovitsanou C; Vassilopoulos D; Sfagos C
    Eur Neurol; 2010; 63(6):350-6. PubMed ID: 20530965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
    J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression in multiple sclerosis: further evidence of an age dependent process.
    Koch M; Mostert J; Heersema D; De Keyser J
    J Neurol Sci; 2007 Apr; 255(1-2):35-41. PubMed ID: 17331540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of birth and disease progression in multiple sclerosis.
    Koch M; De Keyser J; Tremlett H
    Mult Scler; 2008 Jul; 14(6):793-8. PubMed ID: 18573829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.